Printer Friendly
The Free Library
19,604,530 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Criticare Systems, Inc. Announces Receipt of FDA Approval to Market its Proprietary Arrhythmia Detection and Alarm Software.


Business Editors/Health/Medical Writers

MILWAUKEE--(BUSINESS WIRE)--April 30, 2003

CRITICARE SYSTEMS, INC inc - /ink/ increment, i.e. increase by one. Especially used by assembly programmers, as many assembly languages have an "inc" mnemonic.

Antonym: dec.
. (NASDAQ-NMS: CXIM). Criticare Systems Inc. (CSI CSI Crime Scene Investigator
CSI CompuServe, Inc.
CSI Commodity Systems, Inc.
CSI Commodity Systems Inc. (Boca Raton, FL)
CSI Crime Scene Investigation (CBS TV show)
CSI Christian Schools International
) today announced the company received FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
 approval on April 18, 2003 to market its arrhythmia detection and alarm software. This advanced system provides real time analysis of ECG ECG electrocardiogram.

ECG
abbr.
1. electrocardiogram

2. electrocardiograph


ECG
Also called an electrocardiogram, it records the electrical activity of the heart.
 traces and indicates through audio and visual alarms if an abnormality is occurring. Clinical studies to evaluate the performance of the system were conducted at the University of Arizona (body, education) University of Arizona - The University was founded in 1885 as a Land Grant institution with a three-fold mission of teaching, research and public service.  Medical Center.

CSI president and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  Emil Soika stated "We are very pleased to be able to offer this valuable clinical tool. The system will now be offered as an option in the Company's line of full parameter monitors, as well as its VitalView central station

CSI (www.csiusa.com) designs, manufactures, and markets cost-effective patient monitoring systems and noninvasive sensors for a wide range of hospitals and alternate health care environments throughout the world.

This press release contains forward-looking statements. Such statements refer to the Company's beliefs and expectations. Forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those described. Such uncertainties include, but are not limited to, the timely completion of new products, regulatory approvals for new products, the risk of new and better technologies, risks relating to international markets, as well as general conditions and competition in the company's markets. Other risks are set forth in CSI's reports and documents filed from time to time with the Securities and Exchange Commission.
COPYRIGHT 2003 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Apr 30, 2003
Words:250
Previous Article:Kansas State University Captures Top Honors at the Fourth Annual American Express Planning Invitational.
Next Article:S&P Revises Outlook on Developers Diversified Realty.
Topics:



Related Articles
Heart-rhythm drugs found risky for many.
Protocol Systems Inc. Receives Clearance From The FDA To Market Arrhythmia Detection Software For Its Acuity System.
Criticare Systems and Medicomp Introduce Exciting New Product in Joint Development Venture.
Criticare Systems Announces FDA Approval To Market Its Event-Based Paging System.
Criticare Systems, Inc. -CSI- Announces the Creation of a Telemonitoring Subsidiary.
FDA PURCHASES LEADSCOPE ENTERPRISE AND THE TOXSCOPE TOXICITY DATABASES.
Criticare Systems Announces Introduction of the Veris MRI Monitoring System by MEDRAD, INC.
Criticare Systems Announces Record Backlog Exceeding $9MM.
Criticare Systems, Inc. Receives Key Patent Allowance for the Disposable Component of a Respiratory Gas Analyzer.
Criticare Systems, Inc. Announces Contract Award to Supply Vital Signs Monitors for over 50 Domestic Plasma Collection Centers.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles